Neurofilament light chain but not glial fibrillary acidic protein is a potential biomarker of overt hepatic encephalopathy in patients with cirrhosis
Hepatic encephalopathy (HE) is a frequent complication of cirrhosis and may cause cerebral damage. Neurodegenerative diseases can induce the release of neuroproteins like neurofilament light chain (NfL) and glial fibrillary acidic protein (GFAP) in body fluids, including blood plasma. We investigate...
Saved in:
Published in | Annals of hepatology Vol. 29; no. 3; p. 101496 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Mexico
Elsevier España, S.L.U
01.05.2024
Elsevier |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Hepatic encephalopathy (HE) is a frequent complication of cirrhosis and may cause cerebral damage. Neurodegenerative diseases can induce the release of neuroproteins like neurofilament light chain (NfL) and glial fibrillary acidic protein (GFAP) in body fluids, including blood plasma. We investigated whether NfL and GFAP could serve as potential diagnostic plasma biomarkers for overt HE (oHE).
We included 85 patients from three prospective cohorts with different stages of liver disease and HE severity. The following patients were included: 1) 34 patients with primary sclerosing cholangitis (PSC) with compensated disease; 2) 17 patients with advanced liver disease without oHE before elective transjugular intrahepatic portosystemic shunt (TIPS) placement; 3) 17 intensive care unit (ICU) patients with oHE and 17 ICU patients without cirrhosis or oHE. Plasma NfL and GFAP were measured using single molecule assays.
ICU oHE patients had higher NfL concentrations compared to pre-TIPS patients or ICU controls (p < 0.05, each). Median GFAP concentrations were equal in the ICU oHE and pre-TIPS patients or ICU controls. Plasma NfL and GFAP concentrations correlated with Model for End-Stage Liver Disease (MELD) scores (R = 0.58 and R = 0.40, p < 0.001, each).
Plasma NfL deserves further evaluation as potential diagnostic biomarker for oHE and correlates with the MELD score. |
---|---|
AbstractList | Introduction and Objectives: Hepatic encephalopathy (HE) is a frequent complication of cirrhosis and may cause cerebral damage. Neurodegenerative diseases can induce the release of neuroproteins like neurofilament light chain (NfL) and glial fibrillary acidic protein (GFAP) in body fluids, including blood plasma. We investigated whether NfL and GFAP could serve as potential diagnostic plasma biomarkers for overt HE (oHE). Materials and Methods: We included 85 patients from three prospective cohorts with different stages of liver disease and HE severity. The following patients were included: 1) 34 patients with primary sclerosing cholangitis (PSC) with compensated disease; 2) 17 patients with advanced liver disease without oHE before elective transjugular intrahepatic portosystemic shunt (TIPS) placement; 3) 17 intensive care unit (ICU) patients with oHE and 17 ICU patients without cirrhosis or oHE. Plasma NfL and GFAP were measured using single molecule assays. Results: ICU oHE patients had higher NfL concentrations compared to pre-TIPS patients or ICU controls (p < 0.05, each). Median GFAP concentrations were equal in the ICU oHE and pre-TIPS patients or ICU controls. Plasma NfL and GFAP concentrations correlated with Model for End-Stage Liver Disease (MELD) scores (R = 0.58 and R = 0.40, p < 0.001, each). Conclusions: Plasma NfL deserves further evaluation as potential diagnostic biomarker for oHE and correlates with the MELD score. Hepatic encephalopathy (HE) is a frequent complication of cirrhosis and may cause cerebral damage. Neurodegenerative diseases can induce the release of neuroproteins like neurofilament light chain (NfL) and glial fibrillary acidic protein (GFAP) in body fluids, including blood plasma. We investigated whether NfL and GFAP could serve as potential diagnostic plasma biomarkers for overt HE (oHE). We included 85 patients from three prospective cohorts with different stages of liver disease and HE severity. The following patients were included: 1) 34 patients with primary sclerosing cholangitis (PSC) with compensated disease; 2) 17 patients with advanced liver disease without oHE before elective transjugular intrahepatic portosystemic shunt (TIPS) placement; 3) 17 intensive care unit (ICU) patients with oHE and 17 ICU patients without cirrhosis or oHE. Plasma NfL and GFAP were measured using single molecule assays. ICU oHE patients had higher NfL concentrations compared to pre-TIPS patients or ICU controls (p < 0.05, each). Median GFAP concentrations were equal in the ICU oHE and pre-TIPS patients or ICU controls. Plasma NfL and GFAP concentrations correlated with Model for End-Stage Liver Disease (MELD) scores (R = 0.58 and R = 0.40, p < 0.001, each). Plasma NfL deserves further evaluation as potential diagnostic biomarker for oHE and correlates with the MELD score. INTRODUCTION AND OBJECTIVESHepatic encephalopathy (HE) is a frequent complication of cirrhosis and may cause cerebral damage. Neurodegenerative diseases can induce the release of neuroproteins like neurofilament light chain (NfL) and glial fibrillary acidic protein (GFAP) in body fluids, including blood plasma. We investigated whether NfL and GFAP could serve as potential diagnostic plasma biomarkers for overt HE (oHE).MATERIALS AND METHODSWe included 85 patients from three prospective cohorts with different stages of liver disease and HE severity. The following patients were included: 1) 34 patients with primary sclerosing cholangitis (PSC) with compensated disease; 2) 17 patients with advanced liver disease without oHE before elective transjugular intrahepatic portosystemic shunt (TIPS) placement; 3) 17 intensive care unit (ICU) patients with oHE and 17 ICU patients without cirrhosis or oHE. Plasma NfL and GFAP were measured using single molecule assays.RESULTSICU oHE patients had higher NfL concentrations compared to pre-TIPS patients or ICU controls (p < 0.05, each). Median GFAP concentrations were equal in the ICU oHE and pre-TIPS patients or ICU controls. Plasma NfL and GFAP concentrations correlated with Model for End-Stage Liver Disease (MELD) scores (R = 0.58 and R = 0.40, p < 0.001, each).CONCLUSIONSPlasma NfL deserves further evaluation as potential diagnostic biomarker for oHE and correlates with the MELD score. |
ArticleNumber | 101496 |
Author | Beuers, Ulrich Ponsioen, Cyriel Y. de Wit, Koos van Doorn, Diederick J. van Vught, Lonneke A. Nevens, Frederik Mol, Bregje Teunissen, Charlotte E. Takkenberg, R. Bart |
Author_xml | – sequence: 1 givenname: Koos surname: de Wit fullname: de Wit, Koos organization: Department of Gastroenterology and Hepatology, Amsterdam UMC, University of Amsterdam, Amsterdam Gastroenterology Endocrinology and Metabolism, Amsterdam, The Netherlands – sequence: 2 givenname: Diederick J. orcidid: 0000-0003-3299-0654 surname: van Doorn fullname: van Doorn, Diederick J. organization: Department of Gastroenterology and Hepatology, Amsterdam UMC, University of Amsterdam, Amsterdam Gastroenterology Endocrinology and Metabolism, Amsterdam, The Netherlands – sequence: 3 givenname: Bregje surname: Mol fullname: Mol, Bregje organization: Department of Gastroenterology and Hepatology, Amsterdam UMC, University of Amsterdam, Amsterdam Gastroenterology Endocrinology and Metabolism, Amsterdam, The Netherlands – sequence: 4 givenname: Lonneke A. surname: van Vught fullname: van Vught, Lonneke A. organization: Department of Intensive Care, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands – sequence: 5 givenname: Frederik surname: Nevens fullname: Nevens, Frederik organization: Department of Gastroenterology and Hepatology, University Hospitals KU Leuven, Leuven, Belgium – sequence: 6 givenname: Ulrich surname: Beuers fullname: Beuers, Ulrich organization: Department of Gastroenterology and Hepatology, Amsterdam UMC, University of Amsterdam, Amsterdam Gastroenterology Endocrinology and Metabolism, Amsterdam, The Netherlands – sequence: 7 givenname: Cyriel Y. surname: Ponsioen fullname: Ponsioen, Cyriel Y. organization: Department of Gastroenterology and Hepatology, Amsterdam UMC, University of Amsterdam, Amsterdam Gastroenterology Endocrinology and Metabolism, Amsterdam, The Netherlands – sequence: 8 givenname: Charlotte E. orcidid: 0000-0002-4061-0837 surname: Teunissen fullname: Teunissen, Charlotte E. organization: Neurochemistry Laboratory, Department of Clinical Chemistry, Amsterdam Neuroscience, Neurodegeneration, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands – sequence: 9 givenname: R. Bart surname: Takkenberg fullname: Takkenberg, R. Bart email: r.b.takkenberg@amsterdamumc.nl organization: Department of Gastroenterology and Hepatology, Amsterdam UMC, University of Amsterdam, Amsterdam Gastroenterology Endocrinology and Metabolism, Amsterdam, The Netherlands |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/38460714$$D View this record in MEDLINE/PubMed |
BookMark | eNp9UctuEzEUtVARTQtfgIS8ZJPg98wsWKCKR6UKNrC27th3Mg6TcbCdonwI_4unKV2ysn11HtfnXJGLOc5IyGvONpxx8263gTjiYSOYUMtEdeYZWQmju7XuWnFBVtwYvRam5ZfkKucdY0pqLl6QS9kqwxquVuTPVzymOIQJ9jgXOoXtWKgbIcy0PxY6x0K3U4CJDqFPYZognSi44IOjhxQLVlzIFOih3ueyAPsQ95B-YqJxoPEeU6F1SyiVgbPDwwhTrM_xRCt3mVdepr9DGakLKY0xh_ySPB9gyvjq8bwmPz59_H7zZX337fPtzYe7tZNSm7V2jYTW9dp70L0TDFQLUg2s8yhdY7RSxjEnW-F1J5T3ToDixoH3AgZAeU1uz7o-ws4eUqibn2yEYB8GMW0tpLr5hJa3nkPLJAqPCtFBlcVmEK5tGiUaXbXenrVqLr-OmIvdh-ywRjZjPGYrOq2aRmhpKlSeoS7FnBMOT9ac2aVbu7MP3dqlW3vutrLePBoc-z36J86_Mivg_RmANbL7gMlmF5bMfUjoSv1T-K_BX-n4u-4 |
Cites_doi | 10.1016/S0002-9343(02)01477-8 10.14309/ajg.0000000000000343 10.1001/jama.2016.2691 10.18637/jss.v042.i08 10.1038/s41467-020-14612-6 10.1038/s41582-018-0058-z 10.1016/j.jhep.2009.04.009 10.1002/dad2.12321 10.1002/alz.057841 10.1002/lt.21593 10.1136/bmjgast-2020-000531 10.1002/lt.25626 10.1371/journal.pone.0062101 10.1016/j.jceh.2018.05.003 10.14309/ctg.0000000000000419 10.1002/acn3.51188 10.1016/S1474-4422(21)00361-6 10.1038/s41572-022-00366-6 10.1053/j.gastro.2010.02.015 10.1371/journal.pone.0135886 10.1016/j.jhep.2014.05.042 10.1016/j.jhepr.2023.100671 10.1002/acn3.51676 |
ContentType | Journal Article |
Copyright | 2024 Fundación Clínica Médica Sur, A.C. Copyright © 2024 Fundación Clínica Médica Sur, A.C. Published by Elsevier España, S.L.U. All rights reserved. |
Copyright_xml | – notice: 2024 Fundación Clínica Médica Sur, A.C. – notice: Copyright © 2024 Fundación Clínica Médica Sur, A.C. Published by Elsevier España, S.L.U. All rights reserved. |
DBID | 6I. AAFTH CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 DOA |
DOI | 10.1016/j.aohep.2024.101496 |
DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic DOAJ Directory of Open Access Journals |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: DOA name: Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 2659-5982 |
EndPage | 101496 |
ExternalDocumentID | oai_doaj_org_article_18d1a803e2de4eecac38e7f2c8774275 10_1016_j_aohep_2024_101496 38460714 S1665268124002904 |
Genre | Journal Article |
GroupedDBID | --- .1- .FO 0R~ 0SF 1P~ 23M 2WC 53G 5GY 6I. 77H AAEDW AAFTH AAKDD AALRI AAXUO ABXHO ADBBV AENEX AEVXI AEXQZ AFCTW AFRHN AITUG AJUYK AKRWK ALMA_UNASSIGNED_HOLDINGS AMRAJ BAWUL DIK EBD EBS EMOBN F5P FDB GROUPED_DOAJ GX1 M41 NCXOZ OC. OK1 ON0 P2P ROL RSH SV3 TR2 Z5R ADVLN APOWU CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
ID | FETCH-LOGICAL-c3356-5c73a8cb5dda5bc20a48a34f09de3c765446c0c382d5924ddc2a416cadd2afae3 |
IEDL.DBID | DOA |
ISSN | 1665-2681 |
IngestDate | Thu Jul 04 21:10:28 EDT 2024 Sat Aug 17 05:09:33 EDT 2024 Fri Aug 23 02:32:43 EDT 2024 Tue Aug 27 13:50:33 EDT 2024 Sat May 04 15:43:35 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Keywords | PSC Liver diseases Neuroproteins Simoa mHE Metabolism oHE GFAP MELD NfL CSF ICU HE Brain diseases TIPS |
Language | English |
License | This is an open access article under the CC BY-NC-ND license. Copyright © 2024 Fundación Clínica Médica Sur, A.C. Published by Elsevier España, S.L.U. All rights reserved. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c3356-5c73a8cb5dda5bc20a48a34f09de3c765446c0c382d5924ddc2a416cadd2afae3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0003-3299-0654 0000-0002-4061-0837 |
OpenAccessLink | https://doaj.org/article/18d1a803e2de4eecac38e7f2c8774275 |
PMID | 38460714 |
PQID | 2954772536 |
PQPubID | 23479 |
PageCount | 1 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_18d1a803e2de4eecac38e7f2c8774275 proquest_miscellaneous_2954772536 crossref_primary_10_1016_j_aohep_2024_101496 pubmed_primary_38460714 elsevier_sciencedirect_doi_10_1016_j_aohep_2024_101496 |
PublicationCentury | 2000 |
PublicationDate | May-June 2024 2024 May-Jun 2024-05-00 20240501 2024-05-01 |
PublicationDateYYYYMMDD | 2024-05-01 |
PublicationDate_xml | – month: 05 year: 2024 text: May-June 2024 |
PublicationDecade | 2020 |
PublicationPlace | Mexico |
PublicationPlace_xml | – name: Mexico |
PublicationTitle | Annals of hepatology |
PublicationTitleAlternate | Ann Hepatol |
PublicationYear | 2024 |
Publisher | Elsevier España, S.L.U Elsevier |
Publisher_xml | – name: Elsevier España, S.L.U – name: Elsevier |
References | Vermunt, Otte, Verberk, Killestein, Lemstra, van der Flier (bib0023) 2022; 9 Khalil, Teunissen, Otto, Piehl, Sormani, Gattringer (bib0011) 2018; 14 Mayer, Brunkhorst, Niessner, Pfeilschifter, Steinmetz, Foerch (bib0012) 2013; 8 Angelova, Kerbert, Habtesion, Hall, Abramov, Jalan (bib0010) 2022; 4 Hopp, Dirks, Petrusch, Goldbecker, Tryc, Barg-Hock (bib0008) 2019; 25 Khalil, Pirpamer, Hofer, Voortman, Barro, Leppert (bib0024) 2020; 11 Bajaj, Schubert, Heuman, Wade, Gibson, Topaz (bib0007) 2010; 138 Görg, Karababa, Häussinger (bib0009) 2018; 8 de Wit, Schaapman, Nevens, Verbeek, Coenen, Cuperus (bib0020) 2020; 7 Teunissen, Verberk, Thijssen, Vermunt, Hansson, Zetterberg (bib0013) 2022; 21 van Ballegoij, van de Stadt, Huffnagel, Kemp, Willemse, Teunissen, Engelen (bib0022) 2020; 7 (bib0001) 2014; 61 Labenz, Nagel, Kämper, Engel, Bittner, Kaps (bib0015) 2021; 12 (bib0019) 2009; 51 Gairing, Danneberg, Kaps, Nagel, Schleicher, Quack (bib0016) 2023 Smeele, Vermunt, Duitman, Heunks, Blok, Horn (bib0017) 2021; 17 Vågberg, Norgren, Dring, Lindqvist, Birgander, Zetterberg, Svenningsson (bib0025) 2015; 10 Ong, Aggarwal, Krieger, Easley, Karafa, Van Lente (bib0004) 2003; 114 Haj, Rockey (bib0005) 2020; 115 van Vught, Klein Klouwenberg, Spitoni, Scicluna, Wiewel, Horn (bib0021) 2016; 315 Ho, Imai, King, Stuart (bib0018) 2011; 42 Häussinger, Dhiman, Felipo, Görg, Jalan, Kircheis (bib0003) 2022; 8 Sotil, Gottstein, Ayala, Randolph, Blei (bib0006) 2009; 15 Berry, Asken, Grab, Chan, Lario Lago, Wong (bib0014) 2022; 14 (bib0002) 2022 Görg (10.1016/j.aohep.2024.101496_bib0009) 2018; 8 Ong (10.1016/j.aohep.2024.101496_bib0004) 2003; 114 Haj (10.1016/j.aohep.2024.101496_bib0005) 2020; 115 Khalil (10.1016/j.aohep.2024.101496_bib0011) 2018; 14 Labenz (10.1016/j.aohep.2024.101496_bib0015) 2021; 12 (10.1016/j.aohep.2024.101496_bib0002) 2022 Sotil (10.1016/j.aohep.2024.101496_bib0006) 2009; 15 Ho (10.1016/j.aohep.2024.101496_bib0018) 2011; 42 Häussinger (10.1016/j.aohep.2024.101496_bib0003) 2022; 8 Mayer (10.1016/j.aohep.2024.101496_bib0012) 2013; 8 Bajaj (10.1016/j.aohep.2024.101496_bib0007) 2010; 138 Berry (10.1016/j.aohep.2024.101496_bib0014) 2022; 14 Khalil (10.1016/j.aohep.2024.101496_bib0024) 2020; 11 Teunissen (10.1016/j.aohep.2024.101496_bib0013) 2022; 21 (10.1016/j.aohep.2024.101496_bib0019) 2009; 51 Smeele (10.1016/j.aohep.2024.101496_bib0017) 2021; 17 Angelova (10.1016/j.aohep.2024.101496_bib0010) 2022; 4 van Ballegoij (10.1016/j.aohep.2024.101496_bib0022) 2020; 7 de Wit (10.1016/j.aohep.2024.101496_bib0020) 2020; 7 Vermunt (10.1016/j.aohep.2024.101496_bib0023) 2022; 9 Gairing (10.1016/j.aohep.2024.101496_bib0016) 2023 Hopp (10.1016/j.aohep.2024.101496_bib0008) 2019; 25 (10.1016/j.aohep.2024.101496_bib0001) 2014; 61 Vågberg (10.1016/j.aohep.2024.101496_bib0025) 2015; 10 van Vught (10.1016/j.aohep.2024.101496_bib0021) 2016; 315 |
References_xml | – volume: 42 start-page: 1 year: 2011 end-page: 28 ident: bib0018 article-title: MatchIt: nonparametric preprocessing for parametric causal inference publication-title: J Stat Softw contributor: fullname: Stuart – volume: 25 start-page: 1661 year: 2019 end-page: 1672 ident: bib0008 article-title: Hepatic encephalopathy is reversible in the long term after liver transplantation publication-title: Liver Transpl contributor: fullname: Barg-Hock – volume: 15 start-page: 184 year: 2009 end-page: 192 ident: bib0006 article-title: Impact of preoperative overt hepatic encephalopathy on neurocognitive function after liver transplantation publication-title: Liver Transpl contributor: fullname: Blei – volume: 9 start-page: 1832 year: 2022 end-page: 1837 ident: bib0023 article-title: Age- and disease-specific reference values for neurofilament light presented in an online interactive support interface publication-title: Annal Clin Transl Neurol contributor: fullname: van der Flier – volume: 10 year: 2015 ident: bib0025 article-title: Levels and age dependency of neurofilament light and glial fibrillary acidic protein in healthy individuals and their relation to the brain parenchymal fraction publication-title: PLoS One contributor: fullname: Svenningsson – volume: 7 start-page: 2127 year: 2020 end-page: 2136 ident: bib0022 article-title: Plasma NfL and GFAP as biomarkers of spinal cord degeneration in adrenoleukodystrophy publication-title: Ann Clin Transl Neurol contributor: fullname: Engelen – volume: 114 start-page: 188 year: 2003 end-page: 193 ident: bib0004 article-title: Correlation between ammonia levels and the severity of hepatic encephalopathy publication-title: Am J Med contributor: fullname: Van Lente – volume: 8 start-page: 294 year: 2018 end-page: 300 ident: bib0009 article-title: Hepatic encephalopathy and astrocyte senescence publication-title: J Clin Exp Hepatol contributor: fullname: Häussinger – volume: 315 start-page: 1469 year: 2016 end-page: 1479 ident: bib0021 article-title: Incidence, risk factors, and attributable mortality of secondary infections in the intensive care unit after admission for sepsis publication-title: JAMA contributor: fullname: Horn – volume: 7 year: 2020 ident: bib0020 article-title: Prevention of hepatic encephalopathy by administration of rifaximin and lactulose in patients with liver cirrhosis undergoing placement of a transjugular intrahepatic portosystemic shunt (TIPS): a multicentre randomised, double blind, placebo controlled trial (PEARL trial) publication-title: BMJ Open Gastroenterol contributor: fullname: Cuperus – year: 2022 ident: bib0002 article-title: EASL clinical practice guidelines on the management of hepatic encephalopathy publication-title: J Hepatol – volume: 17 year: 2021 ident: bib0017 article-title: Plasma NfL trajectory during ICU-treatment of COVID-19 patients: a prospective cohort study publication-title: Alzheimer's Dementia contributor: fullname: Horn – volume: 12 start-page: e00419 year: 2021 ident: bib0015 article-title: Association between serum levels of neurofilament light chains and minimal hepatic encephalopathy in patients with liver cirrhosis publication-title: Clin Transl Gastroenterol contributor: fullname: Kaps – year: 2023 ident: bib0016 article-title: Elevated serum levels of glial fibrillary acidic protein are associated with covert hepatic encephalopathy in patients with cirrhosis publication-title: JHEP Rep contributor: fullname: Quack – volume: 21 start-page: 66 year: 2022 end-page: 77 ident: bib0013 article-title: Blood-based biomarkers for Alzheimer's disease: towards clinical implementation publication-title: Lancet Neurol contributor: fullname: Zetterberg – volume: 8 start-page: e62101 year: 2013 ident: bib0012 article-title: Blood levels of glial fibrillary acidic protein (GFAP) in patients with neurological diseases publication-title: PLoS One contributor: fullname: Foerch – volume: 11 start-page: 812 year: 2020 ident: bib0024 article-title: Serum neurofilament light levels in normal aging and their association with morphologic brain changes publication-title: Nat Commun contributor: fullname: Leppert – volume: 14 start-page: e12321 year: 2022 ident: bib0014 article-title: Hepatic and renal function impact concentrations of plasma biomarkers of neuropathology publication-title: Alzheimers Dement (Amst) contributor: fullname: Wong – volume: 115 start-page: 723 year: 2020 end-page: 728 ident: bib0005 article-title: Ammonia levels do not guide clinical management of patients with hepatic encephalopathy caused by cirrhosis publication-title: Off J Am College Gastroenterol | ACG contributor: fullname: Rockey – volume: 14 start-page: 577 year: 2018 end-page: 589 ident: bib0011 article-title: Neurofilaments as biomarkers in neurological disorders publication-title: Nat Rev Neurol contributor: fullname: Gattringer – volume: 51 start-page: 237 year: 2009 end-page: 267 ident: bib0019 article-title: EASL clinical practice guidelines: management of cholestatic liver diseases publication-title: J Hepatol – volume: 138 start-page: 2332 year: 2010 end-page: 2340 ident: bib0007 article-title: Persistence of cognitive impairment after resolution of overt hepatic encephalopathy publication-title: Gastroenterology contributor: fullname: Topaz – volume: 8 start-page: 43 year: 2022 ident: bib0003 article-title: Hepatic encephalopathy publication-title: Nat Rev Dis Primers contributor: fullname: Kircheis – volume: 4 year: 2022 ident: bib0010 article-title: Hyperammonaemia induces mitochondrial dysfunction and neuronal cell death publication-title: JHEP Rep contributor: fullname: Jalan – volume: 61 start-page: 642 year: 2014 end-page: 659 ident: bib0001 article-title: 2014 Practice guideline by the european association for the study of the liver and the american association for the study of liver diseases publication-title: J Hepatol – volume: 114 start-page: 188 issue: 3 year: 2003 ident: 10.1016/j.aohep.2024.101496_bib0004 article-title: Correlation between ammonia levels and the severity of hepatic encephalopathy publication-title: Am J Med doi: 10.1016/S0002-9343(02)01477-8 contributor: fullname: Ong – volume: 115 start-page: 723 issue: 5 year: 2020 ident: 10.1016/j.aohep.2024.101496_bib0005 article-title: Ammonia levels do not guide clinical management of patients with hepatic encephalopathy caused by cirrhosis publication-title: Off J Am College Gastroenterol | ACG doi: 10.14309/ajg.0000000000000343 contributor: fullname: Haj – volume: 315 start-page: 1469 issue: 14 year: 2016 ident: 10.1016/j.aohep.2024.101496_bib0021 article-title: Incidence, risk factors, and attributable mortality of secondary infections in the intensive care unit after admission for sepsis publication-title: JAMA doi: 10.1001/jama.2016.2691 contributor: fullname: van Vught – volume: 42 start-page: 1 issue: 8 year: 2011 ident: 10.1016/j.aohep.2024.101496_bib0018 article-title: MatchIt: nonparametric preprocessing for parametric causal inference publication-title: J Stat Softw doi: 10.18637/jss.v042.i08 contributor: fullname: Ho – volume: 11 start-page: 812 issue: 1 year: 2020 ident: 10.1016/j.aohep.2024.101496_bib0024 article-title: Serum neurofilament light levels in normal aging and their association with morphologic brain changes publication-title: Nat Commun doi: 10.1038/s41467-020-14612-6 contributor: fullname: Khalil – volume: 14 start-page: 577 issue: 10 year: 2018 ident: 10.1016/j.aohep.2024.101496_bib0011 article-title: Neurofilaments as biomarkers in neurological disorders publication-title: Nat Rev Neurol doi: 10.1038/s41582-018-0058-z contributor: fullname: Khalil – volume: 51 start-page: 237 issue: 2 year: 2009 ident: 10.1016/j.aohep.2024.101496_bib0019 article-title: EASL clinical practice guidelines: management of cholestatic liver diseases publication-title: J Hepatol doi: 10.1016/j.jhep.2009.04.009 – volume: 14 start-page: e12321 issue: 1 year: 2022 ident: 10.1016/j.aohep.2024.101496_bib0014 article-title: Hepatic and renal function impact concentrations of plasma biomarkers of neuropathology publication-title: Alzheimers Dement (Amst) doi: 10.1002/dad2.12321 contributor: fullname: Berry – year: 2022 ident: 10.1016/j.aohep.2024.101496_bib0002 article-title: EASL clinical practice guidelines on the management of hepatic encephalopathy publication-title: J Hepatol – volume: 17 year: 2021 ident: 10.1016/j.aohep.2024.101496_bib0017 article-title: Plasma NfL trajectory during ICU-treatment of COVID-19 patients: a prospective cohort study publication-title: Alzheimer's Dementia doi: 10.1002/alz.057841 contributor: fullname: Smeele – volume: 15 start-page: 184 issue: 2 year: 2009 ident: 10.1016/j.aohep.2024.101496_bib0006 article-title: Impact of preoperative overt hepatic encephalopathy on neurocognitive function after liver transplantation publication-title: Liver Transpl doi: 10.1002/lt.21593 contributor: fullname: Sotil – volume: 4 issue: 8 year: 2022 ident: 10.1016/j.aohep.2024.101496_bib0010 article-title: Hyperammonaemia induces mitochondrial dysfunction and neuronal cell death publication-title: JHEP Rep contributor: fullname: Angelova – volume: 7 issue: 1 year: 2020 ident: 10.1016/j.aohep.2024.101496_bib0020 publication-title: BMJ Open Gastroenterol doi: 10.1136/bmjgast-2020-000531 contributor: fullname: de Wit – volume: 25 start-page: 1661 issue: 11 year: 2019 ident: 10.1016/j.aohep.2024.101496_bib0008 article-title: Hepatic encephalopathy is reversible in the long term after liver transplantation publication-title: Liver Transpl doi: 10.1002/lt.25626 contributor: fullname: Hopp – volume: 8 start-page: e62101 issue: 4 year: 2013 ident: 10.1016/j.aohep.2024.101496_bib0012 article-title: Blood levels of glial fibrillary acidic protein (GFAP) in patients with neurological diseases publication-title: PLoS One doi: 10.1371/journal.pone.0062101 contributor: fullname: Mayer – volume: 8 start-page: 294 issue: 3 year: 2018 ident: 10.1016/j.aohep.2024.101496_bib0009 article-title: Hepatic encephalopathy and astrocyte senescence publication-title: J Clin Exp Hepatol doi: 10.1016/j.jceh.2018.05.003 contributor: fullname: Görg – volume: 12 start-page: e00419 issue: 10 year: 2021 ident: 10.1016/j.aohep.2024.101496_bib0015 article-title: Association between serum levels of neurofilament light chains and minimal hepatic encephalopathy in patients with liver cirrhosis publication-title: Clin Transl Gastroenterol doi: 10.14309/ctg.0000000000000419 contributor: fullname: Labenz – volume: 7 start-page: 2127 issue: 11 year: 2020 ident: 10.1016/j.aohep.2024.101496_bib0022 article-title: Plasma NfL and GFAP as biomarkers of spinal cord degeneration in adrenoleukodystrophy publication-title: Ann Clin Transl Neurol doi: 10.1002/acn3.51188 contributor: fullname: van Ballegoij – volume: 21 start-page: 66 issue: 1 year: 2022 ident: 10.1016/j.aohep.2024.101496_bib0013 article-title: Blood-based biomarkers for Alzheimer's disease: towards clinical implementation publication-title: Lancet Neurol doi: 10.1016/S1474-4422(21)00361-6 contributor: fullname: Teunissen – volume: 8 start-page: 43 issue: 1 year: 2022 ident: 10.1016/j.aohep.2024.101496_bib0003 article-title: Hepatic encephalopathy publication-title: Nat Rev Dis Primers doi: 10.1038/s41572-022-00366-6 contributor: fullname: Häussinger – volume: 138 start-page: 2332 issue: 7 year: 2010 ident: 10.1016/j.aohep.2024.101496_bib0007 article-title: Persistence of cognitive impairment after resolution of overt hepatic encephalopathy publication-title: Gastroenterology doi: 10.1053/j.gastro.2010.02.015 contributor: fullname: Bajaj – volume: 10 issue: 8 year: 2015 ident: 10.1016/j.aohep.2024.101496_bib0025 article-title: Levels and age dependency of neurofilament light and glial fibrillary acidic protein in healthy individuals and their relation to the brain parenchymal fraction publication-title: PLoS One doi: 10.1371/journal.pone.0135886 contributor: fullname: Vågberg – volume: 61 start-page: 642 issue: 3 year: 2014 ident: 10.1016/j.aohep.2024.101496_bib0001 article-title: 2014 Practice guideline by the european association for the study of the liver and the american association for the study of liver diseases publication-title: J Hepatol doi: 10.1016/j.jhep.2014.05.042 – year: 2023 ident: 10.1016/j.aohep.2024.101496_bib0016 article-title: Elevated serum levels of glial fibrillary acidic protein are associated with covert hepatic encephalopathy in patients with cirrhosis publication-title: JHEP Rep doi: 10.1016/j.jhepr.2023.100671 contributor: fullname: Gairing – volume: 9 start-page: 1832 issue: 11 year: 2022 ident: 10.1016/j.aohep.2024.101496_bib0023 article-title: Age- and disease-specific reference values for neurofilament light presented in an online interactive support interface publication-title: Annal Clin Transl Neurol doi: 10.1002/acn3.51676 contributor: fullname: Vermunt |
SSID | ssj0043512 |
Score | 2.3883476 |
Snippet | Hepatic encephalopathy (HE) is a frequent complication of cirrhosis and may cause cerebral damage. Neurodegenerative diseases can induce the release of... INTRODUCTION AND OBJECTIVESHepatic encephalopathy (HE) is a frequent complication of cirrhosis and may cause cerebral damage. Neurodegenerative diseases can... Introduction and Objectives: Hepatic encephalopathy (HE) is a frequent complication of cirrhosis and may cause cerebral damage. Neurodegenerative diseases can... |
SourceID | doaj proquest crossref pubmed elsevier |
SourceType | Open Website Aggregation Database Index Database Publisher |
StartPage | 101496 |
SubjectTerms | Adult Aged Biomarkers - blood Brain diseases Case-Control Studies Female Glial Fibrillary Acidic Protein - blood Hepatic Encephalopathy - blood Hepatic Encephalopathy - diagnosis Hepatic Encephalopathy - etiology Humans Liver Cirrhosis - blood Liver Cirrhosis - complications Liver Cirrhosis - diagnosis Liver diseases Male Metabolism Middle Aged Neurofilament Proteins - blood Neuroproteins Predictive Value of Tests Prospective Studies Severity of Illness Index |
Title | Neurofilament light chain but not glial fibrillary acidic protein is a potential biomarker of overt hepatic encephalopathy in patients with cirrhosis |
URI | https://dx.doi.org/10.1016/j.aohep.2024.101496 https://www.ncbi.nlm.nih.gov/pubmed/38460714 https://search.proquest.com/docview/2954772536 https://doaj.org/article/18d1a803e2de4eecac38e7f2c8774275 |
Volume | 29 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQDxUXxJstUBmJIxGJHTvOEVCrCqmcqNSbNX6EDVolqyR76A_h_zITJ1U5AJfeImucOJ7J-JvM-DNj7_PC1Lqp68wFobOyUiJzToYsQKEhqlBWM4nr5Td9cVV-vVbXd476opqwRA-cJu5jYUIBJpdRhFjG6MFLE6tGeIPARVSJvbRQazCVfDBigJTn1HMNlylWvqG5sgv6bSSqSlFSS0l8_XfWpJm6_4-l6W_Qc16Czh-zRwt25J_SmJ-wB7F7yo4vl-z4M_YrMW20qGRcSviO4m7utxj7c3eYeNdP_McO7Y03VOeP-h9uOPgWu_OZrgHl2pED3-N1N5Egbc6n-p2B9w2nYs-J40sRySsnj7Dfwq6nM41vOPZdKFpHTv92uW-HYduP7ficXZ2fff9ykS3HLmReSqUz5SsJxjsVAijnRQ6lAVk2eR2i9JVWGEH6HNUggsLoLQQvAGGdR08poIEoX7Cjru_iK8br3LkcGnTGhngI8xq0K4PRBSBQKMBv2Id14u0-sWvYtezsp531ZElPNulpwz6Tcm5FiRp7bkCDsYvB2P8ZzIbpVbV2QRkJPeCt2n8__d1qCBa_QUqsQBf7w2gpV4pRipIo8zJZyO0YJQI82iR2ch9jf80e0oBSweUbdjQNh_gWQdHkTmf7_w0VsAtw |
link.rule.ids | 315,786,790,870,2115,27957,27958 |
linkProvider | Directory of Open Access Journals |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Neurofilament+light+chain+but+not+glial+fibrillary+acidic+protein+is+a+potential+biomarker+of+overt+hepatic+encephalopathy+in+patients+with+cirrhosis&rft.jtitle=Annals+of+hepatology&rft.au=de+Wit%2C+Koos&rft.au=van+Doorn%2C+Diederick+J.&rft.au=Mol%2C+Bregje&rft.au=van+Vught%2C+Lonneke+A.&rft.date=2024-05-01&rft.pub=Elsevier+Espa%C3%B1a%2C+S.L.U&rft.issn=1665-2681&rft.eissn=2659-5982&rft.volume=29&rft.issue=3&rft_id=info:doi/10.1016%2Fj.aohep.2024.101496&rft.externalDocID=S1665268124002904 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1665-2681&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1665-2681&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1665-2681&client=summon |